Alaunos Therapeutics
autologous activated T lymphocyte(Alaunos Therapeutics)은 Relapsed or Advanced Gastric Adenocarcin 표적 세포·유전자 치료로, Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer 영역에서 개발·상용화 중입니다. 작용기전: , and their overall impact on melanoma immunogenicity and antitumoral T cell responses remains unclear. 전임상 단계입니다. PFS: 2.8. 차별점: novel pathways that might be therapeutically exploited to enhance CD8 + T cell-mediated anti-tumor immunity in ex vivo and in.
Relapsed or Advanced Gastric Adenocarcin
Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer
Active
NK cell recognition via the "missing-self" response
linker and characterized by ESI-MS and UV spectrophotometry
retroviral therapy (ART) and evade immune clearance
novel pathways that might be therapeutically exploited to enhance CD8 + T cell-mediated anti-tumor immunity in ex vivo and in
, and their overall impact on melanoma immunogenicity and antitumoral T cell responses remains unclear
T cell activation
PD-1 therapy in the group with low CD276 expression
downregulation of Cathepsin S (CTSS)
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Alaunos Therapeutics
autologous activated T lymphocyte(Alaunos Therapeutics)은 Relapsed or Advanced Gastric Adenocarcin 표적 세포·유전자 치료로, Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer 영역에서 개발·상용화 중입니다. 작용기전: , and their overall impact on melanoma immunogenicity and antitumoral T cell responses remains unclear. 전임상 단계입니다. PFS: 2.8. 차별점: novel pathways that might be therapeutically exploited to enhance CD8 + T cell-mediated anti-tumor immunity in ex vivo and in.
Relapsed or Advanced Gastric Adenocarcin
Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer
Active
NK cell recognition via the "missing-self" response
linker and characterized by ESI-MS and UV spectrophotometry
retroviral therapy (ART) and evade immune clearance
novel pathways that might be therapeutically exploited to enhance CD8 + T cell-mediated anti-tumor immunity in ex vivo and in
, and their overall impact on melanoma immunogenicity and antitumoral T cell responses remains unclear
T cell activation
PD-1 therapy in the group with low CD276 expression
downregulation of Cathepsin S (CTSS)
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.